Abstract
Osteoporosis is a major health care problem, which leads to a high incidence of spine, radial, and hip fractures. These are considered major causes of morbidity and mortality in the aging population. Bone mineral density (BMD) is an important determinant of fracture risk. It is now well recognized that a chronically hypoestrogenic state increases bone turnover that, in turn, causes a critical decrease in BMD [1 – 4]. This process is already present in perimenopausal oligomenorrheic women. Although hormone replacement therapy has been reported to prevent the reduction in bone density related to estrogen deficiency [5 – 6], these women cannot benefit from HRT and the sole supplementation of calcium at this phase is unable to arrest the loss in BMD. There are many studies in the literature reporting that the use of low-dose oral contraceptive (OC) administration may be an optimal preventive measure for perimenopausal decrease in radial [7] and vertebral [8] bone density. The observation of a protective effect of OC on the risk of hip fracture [9] is supported by the results of a longitudinal study, showing that, in perimenopausal oligomenorrheic women, the decrease in femoral bone density is reversed by the administration of a low-dose OC preparation [10]. In order to offer further data on this issue, we collected information in the framework of a large cross-sectional study on the characteristics of women around menopause attending a network of first level outpatient menopause clinics in Italy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ott SM. Attainment of peak bone mass. J Clin Endocrinol Metab 1990;71:1082a-82c.
Geusens P, Dequeker J, Verstraeten A, Nijs J. Age-, sex-, and menopause-related changes of femur and peripheral bone: Population study using dual and single photon absorptiometry and radiogrammetry. J Nucl Med 1986;27:1504–9.
Riggs BL, Wahner HW, Dunn WL, Mazess RB, Offord KP, Melton LJ III. Differential changes in bone mineral density of the appendicular and axial skeleton with ageing. J Clin Invest 1981;67:328–35.
Gambacciani M, Spinetti A, De Simone L, et al. The relative contributions of menopause and aging to postmenopausal vertebral osteopenia. J Clin Endocrinol Metab 1993;77(11); 48–52.
Wallach S, Henneman P. Prolonged estrogen therapy in postmenopausal women. JAMA 1959;171:1637–41.
Lindsay R. Estrogen therapy in the prevention and management of osteoporosis. Am J Obstet Gynecol 1987;156:1347–56.
Gambacciani M, Spinetti A, Cappagli B, et al. Hormone replacement therapy in perimenopausal women with a low dose oral contraceptive preparation: Effects on bone mineral density and metabolism Maturitas 1994;19:125–31
Gambacciani M, Spinetti A, Taponeco F, Cappagli B, Piaggesi L, Fioretti P. Longitudinal evaluation of perimenopausal vertebral bone loss: Effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism. Obstet Gynecol 1994 Mar;83(3):392–6
Michaelsson K, Baron JA, Farahmand BY, Persson I., Ljunghall S. Oral-contraceptive use and risk of hip fractures: A case-control study. Lancet 1999;353:1481–84.
Gambacciani M, Ciaponi M, Cappagli B, Benussi C, Genazzani AR. Longitudinal evaluation of perimenopausal femoral bone loss: Effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism. Osteoporosis International 2000; 11:544–48.
World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843. Geneva: WHO; 1994.
Perrone G, Galoppi P, Capri O, Anelli G, Borrello M, Zichella L. Lumbar and femoral bone density in perimenopausal women with irregular cycles. Int J Fertil Menopausal Stud 1995;May-June(3):120–25.
Haenggi W, Casez J-P, Birkhaeuser MH, et al. Bone mineral density in young women with long-standing amenorrhea: Limited effect of hormone replacement therapy with ethinylestradiol and desogestrel. Osteoporos Int. 1994;4:99–103.
Kritz-Silverstein D, Barrett-Connor E. Bone mineral density in postmenopausal women as determined by prior oral contraceptive use. Am J Public Health. 1993;83:100–102.
Rodin A, Murby B, Smith MA, et al. Perimenopausal bone loss in the lumbar spine and neck of femur: A study of 225 Caucasian women. Bone 1990;11:1–5.
Nilas L, Christiansen C. The pathophysiology of peri-and postmenopausal bone loss. Br J Obstet Gynaecol 1989;96:580–87.
Gambacciani M, Spinetti A, Taponeco F. Bone loss in perimenopausal women: A longitudinal study. Maturitas 1994; 18:191–97.
Kleerekoper M, Brienza RS, Schultz LR, et al. Oral contraceptive use may protect against low bone mass. Arch Intern Med. 1991;151:1971–76.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sarti, C.D., Monteleone, P., Gambacciani, M., Parazzini, F. (2002). Oral Contraceptive Use and Risk of Low Bone Density in Women Attending Menopause Clinics in Italy. In: Lobo, R.A., Crosignani, P.G., Paoletti, R., Bruschi, F. (eds) Women’s Health and Menopause. Medical Science Symposia Series, vol 17. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1061-1_28
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1061-1_28
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5375-1
Online ISBN: 978-1-4615-1061-1
eBook Packages: Springer Book Archive